Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to z Scores01:06

Introduction to z Scores

11.0K
A z score (or standardized value) is measured in units of the standard deviation. It tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
11.0K
Introduction to z Scores01:05

Introduction to z Scores

1.2K
A z score (or standardized value) is measured in units of the standard deviation. It indicates how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a zero z score. It is important to note that the mean of the z scores is zero, and the standard deviation is one.
z scores...
1.2K
z Scores and Area Under the Curve01:17

z Scores and Area Under the Curve

18.4K
z scores are the standardized values obtained after converting a normal distribution into a standard normal distribution. A z score is measured in units of the standard deviation. The z score tells you how many standard deviations the value x is above (to the right of) or below (to the left of) the mean, μ. Values of x that are larger than the mean have positive z scores, and values of x that are smaller than the mean have negative z scores. If x equals the mean, then x has a z score of...
18.4K
Drug Classes and Categories01:25

Drug Classes and Categories

3.0K
Drugs can be classified according to their chemical composition or their intended therapeutic application. For instance, anti-infective agents that possess the ability to eliminate pathogens or suppress their growth and reproduction can be grouped based on the organisms they target or their chemical structure. Furthermore, drugs can be divided into prescription, nonprescription, or controlled substances. Prescription medications, such as antibiotics, require oversight from a licensed healthcare...
3.0K
Antibody Structure and Classes01:25

Antibody Structure and Classes

8.4K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
8.4K
z Scores and Unusual Values01:07

z Scores and Unusual Values

11.0K
The z score is one of the three measures of relative standing. It describes the location of a value in a dataset relative to the mean. z scores are obtained after the standardization of the values in a dataset. The z score for the mean is 0.
 This score indicates how far a value is from the mean in terms of standard deviation. For example, if a data value has a z score of +1, the researcher can infer that the particular data value is one standard deviation above the mean. If another data...
11.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histone deacetylase enzyme activity is not the universal anticancer target of HDAC inhibitors.

Signal transduction and targeted therapy·2026
Same author

MARRVEL-MCP: An agentic interface for Mendelian disease discovery via tool-augmented context engineering.

American journal of human genetics·2026
Same author

NeuroNetFusion: enhanced EEG abnormality classification via multi-network TF-IDF feature selection.

Scientific reports·2026
Same author

LA-MARRVEL: A Knowledge-Grounded, Language-Aware LLM Framework for Clinically Robust Rare Disease Gene Prioritization.

ArXiv·2026
Same author

Semi-Supervised Fatty Liver Classification Using Attention-Based Graph Neural Network Models.

Journal of Korean medical science·2026
Same author

ClinPreAI: An Agentic AI System for Early Postpartum Depression Risk Prediction from Multimodal EHR Data.

medRxiv : the preprint server for health sciences·2025

Related Experiment Video

Updated: Jan 22, 2026

Analyzing Mitochondrial Morphology Through Simulation Supervised Learning
12:06

Analyzing Mitochondrial Morphology Through Simulation Supervised Learning

Published on: March 3, 2023

4.7K

ClearF: a supervised feature scoring method to find biomarkers using class-wise embedding and reconstruction.

Sehee Wang1, Hyun-Hwan Jeong2,3, Kyung-Ah Sohn4

  • 1Department of Computer Engineering, Ajou University, Suwon, 16499, South Korea.

BMC Medical Genomics
|July 13, 2019
PubMed
Summary

A new feature scoring method, ClearF, efficiently identifies biomarkers in continuous data. It offers higher accuracy and faster processing than existing techniques, aiding in cancer subtype discovery.

Keywords:
Breast cancerDimension reductionFeature scoringFeature selectionLow-dimensional embeddingMutual information (MI)Principal component analysis (PCA)Reconstruction error

More Related Videos

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.3K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.2K

Related Experiment Videos

Last Updated: Jan 22, 2026

Analyzing Mitochondrial Morphology Through Simulation Supervised Learning
12:06

Analyzing Mitochondrial Morphology Through Simulation Supervised Learning

Published on: March 3, 2023

4.7K
Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

1.3K
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
06:32

Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures

Published on: January 9, 2019

8.2K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Machine Learning

Background:

  • Biomarker discovery relies on effective feature selection methods.
  • Existing methods, including information-theoretic approaches, often suffer from long processing times and information loss due to data discretization.
  • There is a need for efficient feature scoring methods suitable for continuous-valued data.

Purpose of the Study:

  • To propose a novel supervised feature scoring method named ClearF.
  • To develop a method that is suitable for continuous-valued data and reduces computation time.
  • To validate the effectiveness of ClearF in biomarker detection and classification tasks.

Main Methods:

  • ClearF utilizes class-wise low-dimensional embedding and reconstruction error for feature scoring.
  • The method computes a compressed representation of each class and the entire dataset.
  • Feature scores are derived from reconstruction errors, correlating with information-theoretic measurements.

Main Results:

  • ClearF demonstrated higher classification accuracy compared to established methods.
  • The proposed method exhibited significantly lower execution times.
  • Simulation confirmed the correlation between ClearF scores and information-theoretic measurements.

Conclusions:

  • ClearF is an effective and efficient feature scoring method for continuous data.
  • The method successfully identified genes highly associated with breast cancer subtypes in TCGA data.
  • ClearF offers a promising alternative to existing biomarker detection techniques.